Amoxicillin in severe infections: preliminary results.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D000588:Amines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy*; D002214:Capsules; D002648:Child; D002675:Child, Preschool; D003354:Corynebacterium Infections / Q000188:drug therapy; D003967:Diarrhea / Q000139:chemically induced; D004927:Escherichia coli Infections / Q000188:drug therapy; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D008585:Meningitis, Meningococcal / Q000188:drug therapy; D008875:Middle Aged; D010406:Penicillins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D012141:Respiratory Tract Infections / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy; D013290:Streptococcal Infections / Q000188:drug therapy; D013535:Suspensions; D013997:Time Factors; D014552:Urinary Tract Infections / Q000188:drug therapy
D000588:Amines; D002214:Capsules; D010406:Penicillins; D013535:Suspensions